The company said a total of 10,335 participants have been enrolled in the late stage trial. Each participant will be ...

World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...

The government has decided to set up a National Vaccine Fund as a dedicated, professionally managed investment vehicle ...

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

Sanofi has agreed to acquire hepatitis B vaccine manufacturer Dynavax for an equity value of around $2.2bn, bolstering the ...

Valneva and the Serum Institute of India (SII) have ended a license agreement for chikungunya vaccine supply in Asia after ...

The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...

The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we rate it a hold.

Australia issued a precautionary advisory on Abhayrab rabies vaccine after detecting counterfeit doses in India. IIL says the ...